| [1] |
Luna CM，Palma I，Niederman MS，et al.The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia[J].Ann Am Thorac Soc，2016，13（9）：1519-1526.
|
| [5] |
罗百灵，李秀英，王丽静.影响重症肺炎预后的多个因素分析[J].现代生物医学进展，2009，9（3）：502-504.
|
| [6] |
蒋超英，韩丙超，李仕英.呼吸内科混合细菌感染调查分析[J].临床肺科杂志，2013，18（10） ：1774-1776.
|
| [7] |
程珍平，陈元宾，周阳，等.2016-2020年某院鲍氏不动杆菌医院感染直接经济损失分析[J].中华医院感染学杂志，2021，31（16）：2551-2555.
|
| [8] |
李炜，向俊，易晶，等.基于CNKI的2000-2018年我国抗生素滥用的文献计量学分析[J].中国社会医学杂志，2021， 38（3）：344-346.
|
| [2] |
Cillóniz C，Dominedò C，Pericàs JM，et al.Community-acquired pneumonia in critically ill very old patients：a growing problem[J].Eur Respir Rev，2020，29（155）：190126.
|
| [3] |
Kang SH，Jo YH，Lee JH，et al.Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia[J].BMC Emerg Med，2021，21（1）：108.
|
| [4] |
Cao B，Huang Y，She DY，et al.Diagnosis and treatment of community-acquired pneumonia in adults：2016 clinical practice guidelines by the Chinese Thoracic Society，Chinese Medical Association[J].Clin Respir J，2018，12（4）：1320-1360.
|
| [9] |
Metlay JP，Waterer GW，Long AC，et al.Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America[J].Am J Respir Crit Care Med，2019，200（7）：e45-e67.
|
| [10] |
Vardakas KZ，Rafailidis PI，Konstantelias AA，et al.Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study，the patient，the bug or the drug?[J].J Infect，2013，66（5）：401-414.
|
| [11] |
Martin-Loeches I，Torres A.New guidelines for severe community -acquired pneumonia[J].Curr Opin Pulm Med，2021， 27（3）：210-215.
|
| [12] |
Song JH，Huh K，Chung DR.Community-Acquired Pneumonia in the Asia-Pacific Region[J].Semin Respir Crit Care Med，2016，37（6）：839-854.
|
| [13] |
Rastogi R，Yu PC，Deshpande A，et al.Treatment and outcomes among patients ≥85 years hospitalized with community-acquired pneumonia[J].J Investig Med，2022，70（2）：376-382.
|
| [14] |
Dunn SJ，Connor C，McNally A.The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids[J].Curr Opin Microbiol，2019，51：51-56.
|
| [15] |
Kumagai S，Ishida T，Tachibana H，et al.Polybacterial aetiology and outcomes in patients with community-acquired pneumonia[J].Int J Tuberc Lung Dis，2016，20（1）：129-135.
|
| [16] |
Perez AC，Pang B，King LB，et al.Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo[J].Pathog Dis，70（3）：280-288.
|
| [17] |
Montravers P，Harpan A，Guivarch E.Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia[J].Adv Ther，2016，33（2）：151-166.
|
| [18] |
张鹏，陈炎堂，郑伟浩，等.在开放气道下ARDS治疗前后肺部微生态的变化[J].中华危重病急救医学，2021，33（9）：1063-1068.
|
